Introduction: Langzhi Group is a group dedicated to the investment, research and development, production and marketing of pharmaceutical industry. Its drugs include antibacterial and anti-inflammatory, digestive system-esophagus and gastrointestinal drugs, digestive system-hepatobiliary and pancreatic drugs, antipyretic and analgesic, tonic and tranquilizing ophthalmic drugs, cardiovascular and cerebrovascular diseases, urinary system, nervous system, skin vitamins and nutrients, immune function regulation, heat and detoxification, endocrine and metabolism, and respiration.

Legal Representative: Wang Feng.

Established: 2004- 12-28.

Registered capital:105.263 million yuan.

Industrial and commercial registration number:110108007871959.

Enterprise type: limited liability company (natural person investment or holding)

Company Address: Room 809, Yingu Building, No.9 North Fourth Ring West Road, Haidian District, Beijing